Insights

Providing the latest information from our experts at Forge
July, 2 2026 in
Innovating AAV Gene Therapy: From Research to Scalability

Innovating AAV Gene Therapy: From Research to Scalability

May, 26 2026 in
Ohio Lieutenant Governor Jim Tressel Visits Forge

Workforce, Innovation, and Hope: Ohio Lieutenant Governor Jim Tressel Visits Forge

May, 26 2026 in
Genes of Interest

Genes of Interest, our employee spotlight showcasing the individuals behind Forge that...

April, 24 2026 in
Presenting Your Gene Therapy Manufacturing Plan to Investors: What They Expect in 2026 and How to Deliver It

Presenting Your Gene Therapy Manufacturing Plan to Investors: What They Expect in 2026...

March, 31 2026 in
Celebrating Women's History Month at Forge 2026

Celebrating the Women at Forge and Their Stories During Women's History Month

January, 28 2026 in
The History of AAV Gene Therapy: From Scientific Concept to Commercial Manufacturing

The History of AAV Gene Therapy: From Scientific Concept to Commercial Manufacturing

January, 21 2026 in
Marking National Biotechnology Month With Reflections From Our Leaders

Marking National Biotechnology Month With Reflections From Our Leaders

December, 18 2025 in
23 Questions with Ron & Mark on Forge's Facility Dedicated to AAV Manufacturing

23 Questions with Ron & Mark on Forge's Facility Dedicated to AAV Manufacturing

November, 20 2025 in
A New Window Into FDA’s Approach to Bespoke Therapies: Signals, Open Questions, and Our Early Read

A New Window Into FDA’s Approach to Bespoke Therapies: Signals, Open Questions, and Our...

October, 27 2025 in
Potency Assays for Cell and Gene Therapy: A Complete Guide

Potency Assays for Cell and Gene Therapy: A Complete Guide